Fusion Pharmaceuticals is redefining precision oncology with next-generation radioconjugates that deliver alpha-emitting payloads directly to tumors.
Base: $82,377.60 to $108,120.60; Bonus/Equity: Annual Variable Pay Bonus and equity-based long-term incentive program; Benefits: Flex Benefits, Retirement Savings Program, 4 weeks vacation, annual Personal Days
Must-have
Nice-to-have
Not specified